Form 4: BioLife Solutions EVP Aby J. Mathew Sells Shares to Cover Tax Obligations

Aby J. Mathew, EVP & Chief Scientific Officer of BioLife Solutions Inc., sold 1,597 shares of common stock on March 11, 2025, to cover tax withholding obligations related to vesting restricted stock.

Summary

• On March 11, 2025, Aby J. Mathew, the EVP & Chief Scientific Officer of BioLife Solutions Inc. (BLFS), sold 1,597 shares of common stock.
• The sale was executed at a price of $25 per share.
• The transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted on March 8, 2024.
• The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.
• Following the transaction, Mathew directly owns 260,601 shares of BioLife Solutions Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction to cover tax obligations, executed under a pre-existing plan. It doesn't necessarily indicate a positive or negative outlook on the company.

Industry Context

Insider sales are a common occurrence, especially when related to covering tax obligations on vested stock. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on current market information.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, although the explanation provided mitigates this concern.

Key Dates